Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern
about
Bioresorbable scaffolds for percutaneous coronary interventionsDrug-eluting stents versus bare metal stents for angina or acute coronary syndromesDrug-eluting stents versus bare metal stents for angina or acute coronary syndromesStent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Intravascular optical imaging technology for investigating the coronary arteryClinical outcomes of biodegradable polymer drug-eluting stents for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trialsDrug-eluting stents and acute myocardial infarction: A lethal combination or friends?The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical EvidenceSafety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trialsFirst-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patientsSurface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower ThrombogenicityEvaluation of long-term clinical and health service outcomes following coronary artery revascularisation in Western Australia (WACARP): a population-based cohort study protocolLocalized ultrasound enhances delivery of rapamycin from microbubbles to prevent smooth muscle proliferation.Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery.Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expressionBorderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data RegistryVascular response profiles following a nano polymer-free sirolimus-eluting stent implantation assessed by optical coherence tomography in a porcine modelThe effect of cilostazol on stent thrombosis after drug-eluting stent implantationPreclinical study of a biodegradable polymer-based stent with abluminal sirolimus release.Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.Intravascular optical coherence tomography [Invited].Amino acid sequence preferences to control cell-specific organization of endothelial cells, smooth muscle cells, and fibroblasts.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectiveness.Efficacy of sirolimus-eluting stents compared with paclitaxel-eluting stents in an unselected population with coronary artery disease: 24-month outcomes of patients in a prospective non-randomized registry in Southern Turkey.Drug-eluting stentsEndothelialization and in-stent restenosis on the surface of glycoprotein IIIa monoclonal antibody eluting stent.Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis.Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo.A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with CoronarEffects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysisTrends in hospital discharges, management and in-hospital mortality from acute myocardial infarction in Switzerland between 1998 and 2008Impact of the introduction of drug eluting stents on clinical outcomes in patients undergoing percutaneous and surgical coronary artery revascularisation procedures in Western AustraliaCan improvements in our physiological understanding yield information on the utility of endothelial progenitor cell capture stents?Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome.Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients.Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging.Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)Mis-sizing of stent promotes intimal hyperplasia: impact of endothelial shear and intramural stress
P2860
Q21972838-49586B2D-0872-4F09-8A45-5FEB5248AFB3Q24186681-4E8F2FBF-3752-4854-9326-EE570E395FBFQ24235466-45CE8157-798E-4A28-9F85-69627A57C5B6Q26785321-4D869872-D35A-4D22-8995-1951F7A200F7Q26852822-81F8E265-10CC-4099-BD9E-3227117D0A1DQ26859403-563B0854-0254-4118-ACE7-005B4E951B62Q26865052-C2924B49-5341-484C-A640-42B00C50CB32Q28067509-38D50EDE-4518-483D-B572-D70B0AC5E769Q28539865-4F35046D-2A42-4568-8415-8C56F69E8B55Q28543594-EBBA2C4A-8783-4E99-9765-6E9A977413DFQ28551353-AA2D1E42-30F9-4F20-9D87-4BCC46970E6EQ28654972-69926F64-13EC-454C-B80F-98F48B17AF30Q30425418-A8142543-DD32-4373-8A54-CA1511D7D9E8Q30430948-0F347424-93F6-44F5-8AEE-A62E004D8D19Q30575327-DEBC8FFD-4D07-44F5-A926-BA76CC62ED23Q30667055-9EBBBC97-0A04-47F4-8676-06FA17128B55Q33437306-7798A99B-2C09-4213-8CE2-8994EBD067C8Q33598021-1460B1B6-8ED9-4F5E-9C2C-14DDA6FBF24BQ33616230-8C90B49E-A5A7-464F-803C-44DB8B0E2FEAQ33733393-B899971D-97C3-47E4-B2C0-205F03289B1DQ33776274-F58BA282-8D52-4087-BF9B-52966A1D1310Q33824615-4E6D5AF9-2AE4-4F7E-AF40-D9A4E324A911Q33832534-D255BD8B-9503-437A-80A1-60A15DF624F0Q33839384-D6876146-E571-4202-9C02-0A550E174ED6Q33843405-099967CE-D967-4710-9EC4-4E2F2D088D64Q33949407-799E839D-4128-495B-8BAA-956987FA0016Q34091036-52985C60-ACBF-4226-A456-2B4C81194296Q34177967-BC80AC77-6F24-455A-9554-FF74DCB5D7AEQ34203043-8D04256A-6726-44BE-9B99-8B2BA039D4D0Q34230328-F6F74C1E-7B9A-4456-B560-7A3D5535B270Q34354151-579AC06A-5CBA-463E-83FA-BF24A4AA186DQ34452943-611008CF-F2F4-4DF3-AEB8-172E68F6D693Q34636276-94382B7F-9774-4037-A247-90FD3F09A357Q34798419-E97BF29C-2B4B-446F-BAA0-7E9FD2CB2FFAQ34948071-2B4A5B89-461E-4DFF-AB73-3CB0B5B3D18CQ35095856-2DFB7FFF-339E-4CD4-BC87-ED7E289A4EF1Q35126319-5CCC7FC5-147B-4CD6-A023-B4A17000A998Q35132471-6EE8823D-FCE3-42F5-9D43-F8A42C55292CQ35549533-5B1AB642-2FD4-403D-9DE6-D775D5515B7DQ35601426-D137F260-42EA-470B-9CD3-140090C7ED11
P2860
Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Stent thrombosis late after im ...... ng stents: a cause for concern
@ast
Stent thrombosis late after im ...... ng stents: a cause for concern
@en
Stent thrombosis late after im ...... ng stents: a cause for concern
@nl
type
label
Stent thrombosis late after im ...... ng stents: a cause for concern
@ast
Stent thrombosis late after im ...... ng stents: a cause for concern
@en
Stent thrombosis late after im ...... ng stents: a cause for concern
@nl
prefLabel
Stent thrombosis late after im ...... ng stents: a cause for concern
@ast
Stent thrombosis late after im ...... ng stents: a cause for concern
@en
Stent thrombosis late after im ...... ng stents: a cause for concern
@nl
P3181
P1433
P1476
Stent thrombosis late after im ...... ng stents: a cause for concern
@en
P2093
Edoardo Camenzind
P304
1440-55; discussion 1455
P3181
P356
10.1161/CIRCULATIONAHA.106.666800
P407
P577
2007-03-07T00:00:00Z